Rapport Therapeutics (RAPP) Stock Chart & Stock Price History $26.16 +0.39 (+1.49%) As of 11:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rapport Therapeutics Stock Price Performance The Rapport Therapeutics (RAPP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.49%, with a year-to-date return of 47.49%. In the past month, the stock has decreased 0.10%, reflecting recent market activity. As of the latest close, Rapport Therapeutics traded at $25.78 with a market cap of $940.97 million and volume of 450,785 shares. Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.26%1 Month Performance-0.10%3 Month Performance+71.91%Year-To-Date Performance+47.49%1 Year Performance-10.49% RAPP Stock Chart for Thursday, October, 16, 2025 RAPP Chart by TradingView Rapport Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$24.88$25.78+3.62%$26.55$25.17450,785 shs$940.97 million10/14/2025$26.19$24.88-5.00%$26.75$24.87382,703 shs$908.12 million10/13/2025$26.50$26.19-1.17%$27.30$25.95632,687 shs$955.88 million10/10/2025$26.74$26.50-0.90%$27.42$25.79519,118 shs$967.20 million10/09/2025$27.06$26.74-1.18%$27.72$26.71211,500 shs$976.01 million10/08/2025$26.44$27.06+2.34%$27.33$26.03533,254 shs$987.69 million10/07/2025$27.74$26.44-4.69%$27.69$26.33332,942 shs$965.01 million10/06/2025$28.54$27.74-2.80%$29.25$27.43293,250 shs$1.01 billion10/03/2025$28.54$28.54$29.18$27.99219,281 shs$1.04 billion10/02/2025$28.67$28.54-0.45%$29.56$26.00553,270 shs$1.04 billion Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$29.70$28.67-3.47%$30.58$28.17647,102 shs$1.05 billion09/30/2025$27.97$29.70+6.19%$30.72$27.25819,666 shs$1.08 billion09/29/2025$26.59$27.97+5.19%$28.43$26.33837,355 shs$1.02 billion09/26/2025$24.97$26.59+6.49%$26.68$24.601.13 million shs$970.54 million09/25/2025$26.96$24.97-7.38%$26.82$24.65621,051 shs$911.36 million09/24/2025$26.65$26.96+1.16%$27.66$25.76670,478 shs$984.04 million09/23/2025$26.11$26.65+2.07%$27.94$26.06504,563 shs$972.73 million09/22/2025$26.36$26.11-0.95%$26.92$25.55416,529 shs$952.96 million09/19/2025$27.35$26.36-3.62%$28.52$26.251.50 million shs$962.09 million09/18/2025$26.30$27.35+3.99%$27.39$25.96432,287 shs$998.28 million09/17/2025$26.19$26.30+0.42%$27.25$25.65766,135 shs$959.95 million09/16/2025$24.73$26.19+5.90%$26.50$24.431.36 million shs$955.88 million09/15/2025$23.76$24.73+4.08%$25.20$23.41861,406 shs$902.65 million Related Companies KYMR Stock Chart PTGX Stock Chart CRNX Stock Chart ZLAB Stock Chart AKRO Stock Chart ACAD Stock Chart AAPG Stock Chart MIRM Stock Chart LNTH Stock Chart MENS Stock Chart Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPP) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
